Companies Dominating the Soft Tissue Repair Landscape
- 3D Systems
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Biocomposites
- Medtronic plc
- Stryker
- Zimmer Biomet
- Arthrex, Inc.
- ConMed Corporation
- Acumed, LLC
- Integra LifeSciences
- ArthroCare Corporation
Browse Key Market Insights with Data Illustration:
In the News
- 3D Systems, the premier additive manufacturing solutions partner, and Theradaptive, a biopharmaceutical firm pioneering tailored regenerative treatments, announced a commercial agreement that designates 3D Systems as Theradaptive's exclusive 3D printing partner. The businesses seek to provide a revolutionary strategy to promoting bone and tissue regeneration by coating 3D Systems' 3D-printed medical devices with Theradaptive's unique protein-based material-binding variations. This solution has the potential to improve patients' healing and consequently their results.
- Arthrex, a global leader in minimally invasive surgical technology, revealed that its ACL TightRope implant has been cleared by the US Food and Drug Administration (FDA) for pediatric use. The TightRope implant is used to treat orthopedic injuries surgically, and it is the first and only fixation device for anterior cruciate ligament (ACL) injuries that has been certified for pediatric usage. The Arthrex all-epiphyseal approach was designed for skeletally immature patients and entails bypassing the juvenile growth plates when repairing or reconstructing the ACL.
